Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

10.0%

1 terminated/withdrawn out of 10 trials

Success Rate

87.5%

+1.0% vs industry average

Late-Stage Pipeline

20%

2 trials in Phase 3/4

Results Transparency

14%

1 of 7 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

6(66.7%)

Phase 4

1(11.1%)

Phase 3

1(11.1%)

Phase 2

1(11.1%)

9Total

N/A(6)

Phase 4(1)

Phase 3(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT04286139Not ApplicableCompleted

Self-management and HeAlth Promotion in Early-stage Dementia With E-learning for Carers

Role: collaborator

NCT05509387Not ApplicableRecruiting

Investigating if a Stronger tDCS Intensity is More Effective for Improving Naming Ability in People Living With Alzheimer's Disease

Role: collaborator

NCT04590469Not ApplicableWithdrawn

Improving Wellbeing and Health for Care Home Residents During COVID-19

Role: collaborator

NCT03907748Not ApplicableCompleted

Home-based Family Caregiver-delivered Music and Reading Interventions for People With Dementia

Role: collaborator

NCT02450253Phase 2Completed

Perfusion by Arterial Spin Labelling Following Single Dose Tadalafil in Small Vessel Disease (PASTIS) Trial

Role: collaborator

NCT03031184Phase 3Completed

Study of Mirtazapine for Agitation in Dementia

Role: collaborator

NCT03332979Completed

Experiencing Loss and Planning Ahead Study

Role: collaborator

NCT02559700Not ApplicableCompleted

Online Brain Training Intervention for Over 50s

Role: collaborator

NCT02864056Not ApplicableCompleted

The TACIT Trial: TAi ChI for People With demenTia

Role: collaborator

NCT00142324Phase 4Unknown

CALM-AD

Role: collaborator

All 10 trials loaded